Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141
about
Mast cell costimulation by CD226/CD112 (DNAM-1/Nectin-2): a novel interface in the allergic processNatural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approachesRole of gB and pUS3 in Equine Herpesvirus 1 Transfer between Peripheral Blood Mononuclear Cells and Endothelial Cells: a Dynamic In Vitro ModelStructure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptorStructure of human cytomegalovirus UL141 binding to TRAIL-R2 reveals novel, non-canonical death receptor interactionsThe structure of cytomegalovirus immune modulator UL141 highlights structural Ig-fold versatility for receptor bindingPartners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV InfectionGenomic and functional characteristics of human cytomegalovirus revealed by next-generation sequencingPlasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141Recognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT).Deficient major histocompatibility complex-linked innate murine cytomegalovirus immunity in MA/My.L-H2b mice and viral downregulation of H-2k class I proteins.DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins.Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradationQuantitative temporal viromics: an approach to investigate host-pathogen interactionThe human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells.Modulation of natural killer cells by human cytomegalovirus.Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18An epistatic relationship between the viral protein kinase UL97 and the UL133-UL138 latency locus during the human cytomegalovirus lytic cycle.Human Cytomegalovirus Latency: Approaching the Gordian Knot.High-throughput sequence analysis of variants of human cytomegalovirus strains Towne and AD169.Inhibition of the TRAIL death receptor by CMV reveals its importance in NK cell-mediated antiviral defense.Limited dissemination and shedding of the UL128 complex-intact, UL/b'-defective rhesus cytomegalovirus strain 180.92Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cellsReconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication.HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition of infected cells.A novel human cytomegalovirus locus modulates cell type-specific outcomes of infectionProgress toward an elusive goal: current status of cytomegalovirus vaccines.Balancing natural killer cell activation through paired receptors.Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells.Overlapping transcription structure of human cytomegalovirus UL140 and UL141 genes.Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture.The HCMV gH/gL/UL128-131 complex triggers the specific cellular activation required for efficient viral internalization into target monocytes.Open reading frames carried on UL/b' are implicated in shedding and horizontal transmission of rhesus cytomegalovirus in rhesus monkeys.The Transcription and Translation Landscapes during Human Cytomegalovirus Infection Reveal Novel Host-Pathogen Interactions.The Clinical and Pathological Significance of Nectin-2 and DDX3 Expression in Pancreatic Ductal Adenocarcinomas.Cytomegalovirus destruction of focal adhesions revealed in a high-throughput Western blot analysis of cellular protein expression.Reevaluation of the coding potential and proteomic analysis of the BAC-derived rhesus cytomegalovirus strain 68-1.Viral strategies for evading antiviral cellular immune responses of the host.Characterization of human cytomegalovirus UL145 and UL136 genes in low-passage clinical isolates from infected Chinese infants.Activation, coactivation, and costimulation of resting human natural killer cells
P2860
Q24296718-6AFDFAB9-6852-4577-BCE0-B6C68E7C1B44Q26825652-33EE4F07-31F0-4E80-80DA-1E9A8AEA789DQ27321313-320DB157-6902-45CA-BDBD-974328A88BC2Q27651216-DE3DFFC1-2688-441F-8C1B-2770B9A10BB6Q27677202-CB2D9A0E-A62A-4B0B-8983-530A7CA8D087Q27682007-8EEAE8EE-456B-4D7B-95A0-61B4480BDA0BQ28079533-6D5099D2-AA98-4550-8FC5-15BA3B65ACD0Q28541706-DE5706F4-195C-4ACF-A0D8-5F9272065EE4Q28546343-27D9EB48-90AA-40A0-847D-DD7996EF105FQ30402088-E4579231-4063-4E1C-973E-E148CCF9E346Q30441926-D1EE84F6-7E84-4214-B757-9C8E3D16CE54Q30716850-2BC52FDD-D3F9-4800-8455-21429A094BE0Q33553680-E2126665-EED5-49F0-8594-E4826FD677F8Q33722378-66995775-548C-4541-86CD-EB8F5D2FA046Q33744070-DDE9A16B-0F54-4E9B-9DCA-4BB43B16E62AQ33744384-506801C5-9921-4AA7-A0C4-D46613C387CDQ33748410-ACB38971-0380-406F-A8BD-3E7EC61C2F73Q33887700-3390256C-E777-4338-91B5-04B246EB16B5Q33912815-1EA8FCAF-EF87-42DA-9B26-A22497ABA71CQ33913596-D735724A-B049-494E-B4A0-9CDF70FAB482Q34047484-0AE7046D-06EE-4B80-8FD7-66DAA9BEB137Q34059228-63A8ABD8-1E1F-482D-B809-81C1DAAE9E72Q34076490-8BEFD864-FD39-4F0E-85A0-D5AD2C4D58EFQ34090187-21E49C15-E88E-457A-868F-591B5B5D4C4FQ34116205-8ED8326E-4713-46B4-9F3F-E9EE6FEA8F08Q34126265-7EBBA6D3-2F17-41C6-BBB4-CA2385A74490Q34434818-371E3922-4E7A-4A7B-B91D-7E3027EF4475Q34465877-71E55CD3-E7FD-4EC3-8FC1-D61F3A8A233DQ34526520-0D125FB9-505A-492E-8875-4614E331E93AQ34577925-ED1DD302-1D95-447C-B22C-294B9F1118FCQ34642568-E3F82936-E213-42C7-98B1-AEE9E1E330CBQ34819531-D7406A6C-973A-4BD1-AE48-CA1C80B5704EQ35076699-13165157-FF7C-4189-AD02-97855CF843EBQ35850190-D5907771-C3C3-430A-A494-EA441C9E2365Q35947249-661EC8E0-224E-4773-8A72-3277A7ADBFADQ35947629-FC1F39FD-D41A-4A11-A35D-81EFEA480B75Q36154996-A76815E8-7F1D-4202-9EC7-E320BF4E8995Q36276589-3CDAB091-C0C5-4DC7-AA1D-A265B6012CFAQ36516745-20C285C2-F02A-4DE0-BDC0-681A26615B07Q36652166-CF9FE2F4-C878-4F38-B929-1A26CF458BB4
P2860
Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Downregulation of natural kill ...... by human cytomegalovirus UL141
@ast
Downregulation of natural kill ...... by human cytomegalovirus UL141
@en
Downregulation of natural kill ...... by human cytomegalovirus UL141
@nl
type
label
Downregulation of natural kill ...... by human cytomegalovirus UL141
@ast
Downregulation of natural kill ...... by human cytomegalovirus UL141
@en
Downregulation of natural kill ...... by human cytomegalovirus UL141
@nl
prefLabel
Downregulation of natural kill ...... by human cytomegalovirus UL141
@ast
Downregulation of natural kill ...... by human cytomegalovirus UL141
@en
Downregulation of natural kill ...... by human cytomegalovirus UL141
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Downregulation of natural kill ...... by human cytomegalovirus UL141
@en
P2093
Akio Nomoto
Andrew J Davison
Borivoj Vojtesek
Brian P McSharry
Carole Rickards
Christian Sinzger
Cora Griffin
Eddie C Y Wang
Gavin W G Wilkinson
Melanie Armstrong
P2860
P2888
P3181
P356
10.1038/NI1156
P407
P577
2005-02-01T00:00:00Z
P5875
P6179
1002379481